Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer

OBJECTIVE: Tumor mutation burden (TMB) represents a useful biomarker for predicting survival outcomes and immunotherapy response. Here, we aimed to conduct TMB-based gene signature and molecular subtypes in gastric cancer. METHODS: Based on differentially expressed genes (DEGs) between high- and low...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Cheng, Li, Minzhe, Lin, Shaofeng, Xiao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122698/
https://www.ncbi.nlm.nih.gov/pubmed/35601155
http://dx.doi.org/10.1155/2022/4006507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122698/
https://www.ncbi.nlm.nih.gov/pubmed/35601155
http://dx.doi.org/10.1155/2022/4006507

Ejemplares similares